WT1 and leukemia: While the treatment of leukemia-bearing NOD/SCID mice with T cells modified with a WT1-specific TCR eliminated leukemia cells in the bone marrow of most mice, treatment with T cells transduced with a TCR with irrelevant specificity did not diminish the leukemia burden.